Insulin Pump Therapy

Ismat Abdelrhman Alborhan Mohammed

Insulin Pump Therapy

Ismat Abdelrhman Alborhan Mohammed *

Contact

Article Fingerprint

ReserarchID

MR2UC18

AI TAKEAWAY

Connecting with the Eternal Ground

Abstract

Introduction-The conception of administer continuous insulin appeared in the United States in early 1960s. Dr Arnold Kadish was the first individual who intended the primary closed-loop insulin pump tool that functioned by administration of continuous insulin to the patient accompanied with automatic blood glucose detecting. Practically this device was unsuitable because of its oversize.[1] The earliest certified pump for marketable use accessible in 1983 was branded as Nordisk Infuser. In 1970s, Pickup and Keen practice transportable insulin pump device for CSII in type 1 diabetes mellitus individuals. [2][3] In the year 1976 the world saw the invention of first insulin pumps.[4] Recently insulin pumps manufactures shows more improvement. It became less in size and more practical for usage. The American Diabetes Association identify that CSII is as unhurt as multiple injection therapy, when suggested measures are monitored.[5

References

20 Cites in Article

Reference Format

F Alsaleh,F Smith,S Keady,Kmg Taylor (2010). Insulin pumps: from inception to the present and toward the future.
B Bode,H Sabbah,T Gross,L Fredrickson,P Davidson (Jan). Diabetes management in the new millennium using insulin pump therapy.
(1954). Research Funds Available From The American Diabetes Association.
(2008). Initiating Insulin Pump Therapy.
Sachdeva Anupam (2012). Chapter-150 Management of Type 1 Diabetes Mellitus in Children and Adolescents Including Recent Advances.
U (2017). FDA granted marketing approval to the Praxis Extended RAS Panel.
D Bruttomesso,S Costa,A Baritussio (2009). Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
U MiniMed 530GFDA Approval Letter.
Richard Bergenstal,David Klonoff,Satish Garg,Bruce Bode,Melissa Meredith,Robert Slover,Andrew Ahmann,John Welsh,Scott Lee,Francine Kaufman (2013). Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia.
George Grunberger,Timothy Bailey,A Cohen,Thomas Flood,Yehuda Handelsman,Richard Hellman,Lois Jovanovič,Etie Moghissi,Eric Orzeck,Aace Insulin Pump Management Task Force (2010). Statement by the American Association of Clinical Endocrinologists Consensus Panel on Insulin Pump Management.
Moshe Phillip,Tadej Battelino,Henry Rodriguez,Thomas Danne,Francine Kaufman (2007). Use of Insulin Pump Therapy in the Pediatric Age-Group.
Thomas Buchanan,Boyd Metzger,Norbert Freinkel (1990). Accelerated starvation in late pregnancy: A comparison between obese women with and without gestational diabetes mellitus.
Lois Jovanovic,Maurice Druzin,Charles Peterson (1981). Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects.
&na; (2119). Continuous subcutaneous insulin infusion (CSII) has long-term benefits in children and adolescents with type 1 diabetes mellitus.
(2015). Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus|Guidance and guidelines|NICE.
Steven Brown (1995). Pirouette, Version 1.22, available from Infometrix, Inc., 17270 Woodinville‐Redmond Road NE, Suite 777, Woodinville, WA 98072, U.S.A. Telephone (+ 1 206) 402–1450, telefax (+ 1 206) 402–1040, Internet: infomtrx©halcyon.com. WWW: http://www.halcyon.com/infomtrx/. Prices: $4000 commercial, $2400 academic; volume discounts are available.
B Bode,J Kyllo,F Kaufman (2013). Pumping Protocol: A Guide to Insulin Pump Initiation.
(1998). Continuous Subcutaneous Insulin Infusion.
Maria Kitanova (2019). Axiological aspects of some models of euphimisation in Bulgarian language and traditional Bulgarian culture.
Mary Boyle,Karen Seifert,Karen Beer,Heidi Apsey,Adrienne Nassar,Stephanie Littman,Janice Magallanez,Richard Schlinkert,Joshua Stearns,Michael Hovan,Curtiss Cook (2012). Guidelines for Application of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Perioperative Period.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Ismat Mohammed. 2021. "Insulin Pump Therapy". Global Journal of Medical Research, Global Journal of Medical Research - F: Diseases GJMR-F Volume 21 (GJMR Volume 21 Issue F2).

More Citation Formats

Select Citation Style:

Download Citation

GJMR Volume 21 Issue F2

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmr

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-F Classification NLMC Code: WK 820

Submission ReceivedFebruary 9, 2021
Peer Review Double Blind
Handling Editor
Accepted March 2, 2021
Published March 15, 2021

Version of record

v1.2

Issue date

April 22, 2021

Language

English

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 780

Total Downloads: 69

All Trends